Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,318 public trials 1,292 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

NCT01902173

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +25 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • California Pacific Medical Center-Pacific Campus San Francisco, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma

NCT04382664

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California Irvine Health Orange, California, United States
  • California Cancer Associates for Research & Excellence (CCARE San Marcos, California, United States
View all 37 locations
View Trial Details
Completed

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

NCT02323880

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

NCT03914742

Conditions
Astrocytoma, Glioblastoma, Glioma, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.

NCT03980925

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +6 more
Locations
  • Institut Català d'Oncologia Badalona Badalona, Barcelona, Spain
  • Institut Català d'Oncologia l'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Vall d'Hebron University Hospital Barcelona, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
View Trial Details
Completed

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

NCT04121676

Conditions
Advanced Cancer, Melanoma, Neoplasms, +10 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center/ Hoag Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions